JULY 31: PROSTABLOG NZ: Prostate cancer patients who think drinking calcium-fortified trim milk is a good way to maintain health need to read this.
Archive for July, 2009
If you’ve got prostate cancer and you’re drinking calcium-rich trim milk, STOP!
Posted in Calcium, PROSTATE CANCER, PROSTATE RESEARCH, PROSTATE RISKS, Soy, tagged almonds, Calcium, cancer research, Dr Jim Watson, Dr Richard Forster, immunologist, Natural remedies, prostablog, prostate, prostate blog, PROSTATE CANCER, Prostate Cancer Foundation, Prostate Cancer Foundation of NZ, soy milk, super-trim milk, yellow cartons on July 31, 2009 | Leave a Comment »
‘Nomograms’ best way to predict whether you’ll survive prostate cancer and for how long
Posted in Biopsy, Diagnosis, Doctors' advice, Gleason grade, PROSTATE CANCER, Prostate prognosis, PROSTATE RESEARCH, PSA tests, Screening debate, tagged Biopsy, cancer research, comparison of treatments, Gleason grade, individual life expectancy, newly diagnosed prostate cancer, nomogram, nomogram accuracy, prostablog, prostate, prostate blog, PROSTATE CANCER, Prostate prognosis, prostate-specific antigen, PSA, PSA test, Screening debate, Sloan Kettering, University of Montreal Health Center, URO TODAY on July 31, 2009 | Leave a Comment »
JULY 31: URO TODAY: What’s the most accurate way your specialist can predict your fate when you first learn you have prostate cancer? Using something called a nomogram, according to latest analysis.
NZ health ministry publishes new set of guidelines for cancer nurses
Posted in PROSTATE CANCER, Public health system, tagged cancer nurses, guidelines, NZ Ministry of Health, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments on July 31, 2009 | Leave a Comment »
JULY 31: NZ MINISTRY OF HEALTH: A set of guidelines for registered working in cancer control has just been published by the New Zealand Ministry of Health.
Continuity of care from ‘trusted’ health carers is key to cutting prostate cancer risks
Posted in PROSTATE CANCER, tagged African-American men, continuity of care, journal Cancer, medical checkups, MEDICAL NEWS TODAY, prostablog, prostate, prostate blog, PROSTATE CANCER, Trusted health care sources on July 31, 2009 | Leave a Comment »
JULY 31: MEDICAL NEWS TODAY: Trusted health care sources and continuity of care may help reduce the risk of prostate cancer deaths in African-American men, according to a study published in the current issue of the journal Cancer.
Indian men in NZ urged to get themselves tested for prostate cancer
Posted in PROSTATE CANCER, PSA tests, Screening debate, tagged blood test, blood tests, Dr Jackie Blue, Indian community in NZ, Indian men, INDIAN NEWSLINK, National list MP, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate-specific antigen, PSA, PSA test, Screening debate on July 31, 2009 | Leave a Comment »
JULY 31: INDIAN NEWSLINK: NZ politician Dr Jackie Blue (a National list MP) is urging men in the country’s Indian communities to avail themselves of cancer screening.
Rapid knowledge gain about hormone therapy resistance opportunity for development of new drugs
Posted in Hormone therapy, Hormone-refactory, PROSTATE CANCER, PROSTATE RESEARCH, Treatment debate, tagged advanced prostate cancer, Amsterdam, androgen-deprivation therapy, cancer research, Departments of Urology, Dutch researchers, Erasmus Medical Centre, Hormone therapy, hormone-naïve to castration-resistant, molecular and cellular changes, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate drug development, prostate treatment, prostate treatment debate, Rotterdam, URO TODAY, VU Medical Centre on July 31, 2009 | Leave a Comment »
JULY 31: URO TODAY: Knowledge of the molecular and cellular changes that occur during the transition of hormone-naïve to castration-resistant prostate cancer is increasing rapidly.
Various immune cells found in hormone therapy patients may lift or cut risk of advanced prostate cancer
Posted in Hormone therapy, PROSTATE CANCER, PROSTATE RESEARCH, PROSTATE RISKS, tagged advanced prostate cancer, androgen-deprivation therapy, cancer research, CD56(+) Natural Killer cells, CD68(+) macrophages, immune cells, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer progression, Research Centre of the Centre Hospitalier de l'Université de Montréal, URO TODAY on July 31, 2009 | Leave a Comment »
JULY 31: URO TODAY: Higher levels of immune cells called CD68(+) macrophages found in patients having androgen deprivation therapy may be associated with greater risk of advanced prostate cancer, according to a study in Quebec.
Fundamental change to US medical system depends on ‘prostate cancer test’
Posted in PROSTATE CANCER, Public health system, Treatment news, tagged David Leonhardt, mediocre results, New York Times, President Obama, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment debate, soaring costs, US Congress, US medical system costs on July 31, 2009 | Leave a Comment »
JULY 31: David Leonhardt, NEW YORK TIMES: The “prostate cancer test” will determine whether President Obama and Congress put together a bill that begins to fix the fundamental problem with our medical system: the combination of soaring costs and mediocre results.
Researchers look at outcome of combining brachytherapy with whole-pelvis radiotherapy to treat high-risk prostate cancer
Posted in Brachytherapy, PROSTATE CANCER, PROSTATE RESEARCH, Radiotherapy, Treatment debate, tagged Brachytherapy, cancer research, high risk prostate cancer, interstitial brachytherapy, lympth nodes, pelvic lymph nodes, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Radiotherapy, URO TODAY, whole-pelvis radiotherapy on July 31, 2009 | Leave a Comment »
JULY 31: URO TODAY: Researchers have investigated whether whole-pelvis radiotherapy in combination with interstitial brachytherapy – thus covering the pelvic lymph nodes – improves treatment outcome in high-risk prostate cancer.









